Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06370182 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
A NA study of Acute Ischemic Stroke From Large Vessel Occlusion, sponsored by Anaconda Biomed S.L..
- Recruiting
- Registry status
- NA
- Development phase
- 327
- Enrollment target
- 20
- Study locations
NCT06370182: Recruiting NA study of Acute Ischemic Stroke From Large Vessel Occlusion, sponsored by Anaconda Biomed S.L..
NCT06370182 is a NA study of Acute Ischemic Stroke From Large Vessel Occlusion that is actively recruiting participants, run by Anaconda Biomed S.L.. The registered enrollment target is 327 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06370182, a NA study of Acute Ischemic Stroke From Large Vessel Occlusion, is actively recruiting participants, sponsored by Anaconda Biomed S.L..
- RECRUITING
- Registry status
- NA
- Development phase
- 327 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this study is to assess the safety and effectiveness of mechanical thrombectomy (MT) using the ANA funnel catheter in its intended use, which is to facilitate the navigation and deployment of other neurovascular devices and to allow flow arrest during mechanical thrombectomy procedures performed in subjects experiencing acute ischemic stroke (AIS) secondary to large vessel occlusion (LVO) and treated within 24 hours of symptom onset.
Primary Outcome
Reperfusion (eTICI 2c-3) to be assessed by an independent Core Lab.
Conditions Studied
Interventions
- DEVICE Control
- DEVICE ANA Funnel Catheter
Study Locations (20)
Other
- Centre Hospitalier Universitaire de Montpellier - Montpellier
- Fondation Rothschild - Paris
- Hospital Foch - Suresnes
- Centre Hospitalier Universitaire de Toulouse - Toulouse
- Semmelweis University Hospital - Budapest
- Hospital Universitario Vall D'Hebron - Barcelona
- Hospital Clinic de Barcelona - Barcelona
- Hospital Clinico San Carlos - Madrid
- Hospital Virgen de la Arrixaca - Murcia
New York
- University of Buffalo Neurosurgery - Buffalo
- Mount Sinai Hospital - New York
Florida
- Baptist Health Medical Center - Jacksonville
Georgia
- Grady Memorial Hospital, Emory - Atlanta
Illinois
- Advocate Health - Park Ridge
Iowa
- University of Iowa - Iowa City
Massachusetts
- Boston Medical Center - Boston
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2024-09-09 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06370182 shows while recruiting
NCT06370182 is an interventional study that assigns participants to a tested intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Acute Ischemic Stroke From Large Vessel Occlusion appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT06370182 names 20 study sites across 11 states, led by Other, New York, Florida.
Frequently Asked Questions
What is clinical trial NCT06370182 about?
NCT06370182 is a clinical study titled "Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter". The objective of this study is to assess the safety and effectiveness of mechanical thrombectomy (MT) using the ANA funnel catheter in its intended use, which is to facilitate the navigation and deployment of other neurovascular devices and to allow flow arrest during mechanical thrombectomy procedu...
What is the current status of trial NCT06370182?
This trial is currently recruiting. It is a NA study. The enrollment target is 327 participants. The study started on 2024-09-09. Estimated completion is 2027-12.
What conditions does trial NCT06370182 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke From Large Vessel Occlusion.
What interventions are being tested in trial NCT06370182?
The interventions under investigation include: Control (DEVICE), ANA Funnel Catheter (DEVICE).
Who is sponsoring clinical trial NCT06370182?
This trial is sponsored by Anaconda Biomed S.L., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06370182 being conducted?
This trial has 20 study locations across Florida, Georgia, Illinois, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke From Large Vessel Occlusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06370182's enrollment target sits among peer trials
327 309th of 2000 higher than 1,692 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
- NCT05548413 · 328 participants · NA
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI